Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. The Global Cancer Observatory. Globocan—Portugal, https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf; 2020. Accessed 20 Feb 2023.
2. The Global Cancer Observatory. Globocan—World, https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf; 2020. Accessed 20 Feb 2023.
3. Cameron LB, Hitchen N, Chandran E, Morris T, Manser R, Solomon BJ, et al. Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer. Cochrane Database Syst Rev. 2022;1(1):CD013453. https://doi.org/10.1002/14651858.CD013453.pub2.
4. Hirsch FR, Suda K, Wiens J, Bunn PA Jr. New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet. 2016;388(10048):1012–24. https://doi.org/10.1016/S0140-6736(16)31473-8.
5. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–6. https://doi.org/10.1038/nature05945.